QJM-INT J MED 润色咨询

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

出版年份:1994 年文章数:557 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:14.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:内科<br>经验分享:很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向:QJM<br>经验分享:这个杂志影响因子这么高,为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家,病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:耳鼻喉;案例报告<br>经验分享:投的是案例报告,5月31号投稿,6月1号编辑回信建议删图,当天删图后再提交,6月2号immediately accepted,虽然只是案例报告,但是我第一篇接收的,科研小菜鸟很开心,对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0<br>经验分享:case report~2月21号投稿,24号编辑回信建议修改格式,24号按要求改格式、删图,25号编辑审稿后直接修回,26号修后再投,27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:在第一篇肺癌的基础上,我又投了一篇个案报道,脂肪平滑肌肉瘤,更是荣幸地immediately accepted,导致我现在很喜欢这个杂志,原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:不清楚<br>经验分享:心内文章,20小时内秒拒,没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226347, encodeId=2c6c122634eee, content=最近在QJM投稿一篇,第二天就状态就显示ADM:awaiting reviewer selection。到现在第七天,状态依旧没变化。希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Tue Jun 14 10:40:16 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2023-08-14 翊翊翊 来自山东省

    能投生信类文章吗?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:内科<br>经验分享:很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向:QJM<br>经验分享:这个杂志影响因子这么高,为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家,病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:耳鼻喉;案例报告<br>经验分享:投的是案例报告,5月31号投稿,6月1号编辑回信建议删图,当天删图后再提交,6月2号immediately accepted,虽然只是案例报告,但是我第一篇接收的,科研小菜鸟很开心,对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0<br>经验分享:case report~2月21号投稿,24号编辑回信建议修改格式,24号按要求改格式、删图,25号编辑审稿后直接修回,26号修后再投,27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:在第一篇肺癌的基础上,我又投了一篇个案报道,脂肪平滑肌肉瘤,更是荣幸地immediately accepted,导致我现在很喜欢这个杂志,原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:不清楚<br>经验分享:心内文章,20小时内秒拒,没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226347, encodeId=2c6c122634eee, content=最近在QJM投稿一篇,第二天就状态就显示ADM:awaiting reviewer selection。到现在第七天,状态依旧没变化。希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Tue Jun 14 10:40:16 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2023-05-16 ms3000001779537693 来自北京

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向:内科
    经验分享:很难投中

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:内科<br>经验分享:很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向:QJM<br>经验分享:这个杂志影响因子这么高,为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家,病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:耳鼻喉;案例报告<br>经验分享:投的是案例报告,5月31号投稿,6月1号编辑回信建议删图,当天删图后再提交,6月2号immediately accepted,虽然只是案例报告,但是我第一篇接收的,科研小菜鸟很开心,对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0<br>经验分享:case report~2月21号投稿,24号编辑回信建议修改格式,24号按要求改格式、删图,25号编辑审稿后直接修回,26号修后再投,27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:在第一篇肺癌的基础上,我又投了一篇个案报道,脂肪平滑肌肉瘤,更是荣幸地immediately accepted,导致我现在很喜欢这个杂志,原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:不清楚<br>经验分享:心内文章,20小时内秒拒,没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226347, encodeId=2c6c122634eee, content=最近在QJM投稿一篇,第二天就状态就显示ADM:awaiting reviewer selection。到现在第七天,状态依旧没变化。希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Tue Jun 14 10:40:16 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2023-04-28 ms1000000619009997 来自湖北省

    偏重的研究方向:QJM
    经验分享:这个杂志影响因子这么高,为啥中科院分区这么低

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:内科<br>经验分享:很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向:QJM<br>经验分享:这个杂志影响因子这么高,为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家,病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:耳鼻喉;案例报告<br>经验分享:投的是案例报告,5月31号投稿,6月1号编辑回信建议删图,当天删图后再提交,6月2号immediately accepted,虽然只是案例报告,但是我第一篇接收的,科研小菜鸟很开心,对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0<br>经验分享:case report~2月21号投稿,24号编辑回信建议修改格式,24号按要求改格式、删图,25号编辑审稿后直接修回,26号修后再投,27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:在第一篇肺癌的基础上,我又投了一篇个案报道,脂肪平滑肌肉瘤,更是荣幸地immediately accepted,导致我现在很喜欢这个杂志,原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:不清楚<br>经验分享:心内文章,20小时内秒拒,没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226347, encodeId=2c6c122634eee, content=最近在QJM投稿一篇,第二天就状态就显示ADM:awaiting reviewer selection。到现在第七天,状态依旧没变化。希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Tue Jun 14 10:40:16 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2023-01-10 ms7000001910214771 来自辽宁省

    想问一下大家,病例awaiting reviewer selection需要多久才能送审啊

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:内科<br>经验分享:很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向:QJM<br>经验分享:这个杂志影响因子这么高,为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家,病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:耳鼻喉;案例报告<br>经验分享:投的是案例报告,5月31号投稿,6月1号编辑回信建议删图,当天删图后再提交,6月2号immediately accepted,虽然只是案例报告,但是我第一篇接收的,科研小菜鸟很开心,对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0<br>经验分享:case report~2月21号投稿,24号编辑回信建议修改格式,24号按要求改格式、删图,25号编辑审稿后直接修回,26号修后再投,27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:在第一篇肺癌的基础上,我又投了一篇个案报道,脂肪平滑肌肉瘤,更是荣幸地immediately accepted,导致我现在很喜欢这个杂志,原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:不清楚<br>经验分享:心内文章,20小时内秒拒,没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226347, encodeId=2c6c122634eee, content=最近在QJM投稿一篇,第二天就状态就显示ADM:awaiting reviewer selection。到现在第七天,状态依旧没变化。希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Tue Jun 14 10:40:16 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2022-06-03 ms7000001370020190

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:耳鼻喉;案例报告
    经验分享:投的是案例报告,5月31号投稿,6月1号编辑回信建议删图,当天删图后再提交,6月2号immediately accepted,虽然只是案例报告,但是我第一篇接收的,科研小菜鸟很开心,对这个杂志太有好感啦

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:内科<br>经验分享:很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向:QJM<br>经验分享:这个杂志影响因子这么高,为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家,病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:耳鼻喉;案例报告<br>经验分享:投的是案例报告,5月31号投稿,6月1号编辑回信建议删图,当天删图后再提交,6月2号immediately accepted,虽然只是案例报告,但是我第一篇接收的,科研小菜鸟很开心,对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0<br>经验分享:case report~2月21号投稿,24号编辑回信建议修改格式,24号按要求改格式、删图,25号编辑审稿后直接修回,26号修后再投,27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:在第一篇肺癌的基础上,我又投了一篇个案报道,脂肪平滑肌肉瘤,更是荣幸地immediately accepted,导致我现在很喜欢这个杂志,原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:不清楚<br>经验分享:心内文章,20小时内秒拒,没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226347, encodeId=2c6c122634eee, content=最近在QJM投稿一篇,第二天就状态就显示ADM:awaiting reviewer selection。到现在第七天,状态依旧没变化。希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Tue Jun 14 10:40:16 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2020-02-28 molly12345

    审稿速度:1.0
    经验分享:case report~2月21号投稿,24号编辑回信建议修改格式,24号按要求改格式、删图,25号编辑审稿后直接修回,26号修后再投,27号立即接受

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:内科<br>经验分享:很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向:QJM<br>经验分享:这个杂志影响因子这么高,为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家,病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:耳鼻喉;案例报告<br>经验分享:投的是案例报告,5月31号投稿,6月1号编辑回信建议删图,当天删图后再提交,6月2号immediately accepted,虽然只是案例报告,但是我第一篇接收的,科研小菜鸟很开心,对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0<br>经验分享:case report~2月21号投稿,24号编辑回信建议修改格式,24号按要求改格式、删图,25号编辑审稿后直接修回,26号修后再投,27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:在第一篇肺癌的基础上,我又投了一篇个案报道,脂肪平滑肌肉瘤,更是荣幸地immediately accepted,导致我现在很喜欢这个杂志,原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:不清楚<br>经验分享:心内文章,20小时内秒拒,没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226347, encodeId=2c6c122634eee, content=最近在QJM投稿一篇,第二天就状态就显示ADM:awaiting reviewer selection。到现在第七天,状态依旧没变化。希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Tue Jun 14 10:40:16 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2018-05-25 qiangq

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:在第一篇肺癌的基础上,我又投了一篇个案报道,脂肪平滑肌肉瘤,更是荣幸地immediately accepted,导致我现在很喜欢这个杂志,原来在英国学习时也是读过纸质版。最近正在约一篇综述。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:内科<br>经验分享:很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向:QJM<br>经验分享:这个杂志影响因子这么高,为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家,病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:耳鼻喉;案例报告<br>经验分享:投的是案例报告,5月31号投稿,6月1号编辑回信建议删图,当天删图后再提交,6月2号immediately accepted,虽然只是案例报告,但是我第一篇接收的,科研小菜鸟很开心,对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0<br>经验分享:case report~2月21号投稿,24号编辑回信建议修改格式,24号按要求改格式、删图,25号编辑审稿后直接修回,26号修后再投,27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:在第一篇肺癌的基础上,我又投了一篇个案报道,脂肪平滑肌肉瘤,更是荣幸地immediately accepted,导致我现在很喜欢这个杂志,原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:不清楚<br>经验分享:心内文章,20小时内秒拒,没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226347, encodeId=2c6c122634eee, content=最近在QJM投稿一篇,第二天就状态就显示ADM:awaiting reviewer selection。到现在第七天,状态依旧没变化。希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Tue Jun 14 10:40:16 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2022-10-25 ms9000000375851820

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:不清楚
    经验分享:心内文章,20小时内秒拒,没有原因

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:内科<br>经验分享:很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向:QJM<br>经验分享:这个杂志影响因子这么高,为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家,病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:耳鼻喉;案例报告<br>经验分享:投的是案例报告,5月31号投稿,6月1号编辑回信建议删图,当天删图后再提交,6月2号immediately accepted,虽然只是案例报告,但是我第一篇接收的,科研小菜鸟很开心,对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0<br>经验分享:case report~2月21号投稿,24号编辑回信建议修改格式,24号按要求改格式、删图,25号编辑审稿后直接修回,26号修后再投,27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:在第一篇肺癌的基础上,我又投了一篇个案报道,脂肪平滑肌肉瘤,更是荣幸地immediately accepted,导致我现在很喜欢这个杂志,原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:不清楚<br>经验分享:心内文章,20小时内秒拒,没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226347, encodeId=2c6c122634eee, content=最近在QJM投稿一篇,第二天就状态就显示ADM:awaiting reviewer selection。到现在第七天,状态依旧没变化。希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Tue Jun 14 10:40:16 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2022-10-19 ms5000001621098193

    这杂志怎么突然涨分那么多????

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2152730, encodeId=85cd2152e3095, content=能投生信类文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Mon Aug 14 19:32:16 CST 2023, time=2023-08-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2134926, encodeId=4cd6213492636, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:内科<br>经验分享:很难投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d135645061, createdName=ms3000001779537693, createdTime=Tue May 16 11:12:50 CST 2023, time=2023-05-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128979, encodeId=846d21289e979, content=偏重的研究方向:QJM<br>经验分享:这个杂志影响因子这么高,为啥中科院分区这么低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fcd5577567, createdName=ms1000000619009997, createdTime=Fri Apr 28 11:58:38 CST 2023, time=2023-04-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2109652, encodeId=7c8c21096520c, content=想问一下大家,病例awaiting reviewer selection需要多久才能送审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e495467216, createdName=ms7000001910214771, createdTime=Tue Jan 10 12:22:38 CST 2023, time=2023-01-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1224247, encodeId=60f7122424eb7, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:耳鼻喉;案例报告<br>经验分享:投的是案例报告,5月31号投稿,6月1号编辑回信建议删图,当天删图后再提交,6月2号immediately accepted,虽然只是案例报告,但是我第一篇接收的,科研小菜鸟很开心,对这个杂志太有好感啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80996474237, createdName=ms7000001370020190, createdTime=Fri Jun 03 14:18:31 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585501, encodeId=70fd585501f5, content=审稿速度:1.0<br>经验分享:case report~2月21号投稿,24号编辑回信建议修改格式,24号按要求改格式、删图,25号编辑审稿后直接修回,26号修后再投,27号立即接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=963a73788, createdName=molly12345, createdTime=Fri Feb 28 00:00:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556444, encodeId=b548556444e4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:在第一篇肺癌的基础上,我又投了一篇个案报道,脂肪平滑肌肉瘤,更是荣幸地immediately accepted,导致我现在很喜欢这个杂志,原来在英国学习时也是读过纸质版。最近正在约一篇综述。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4dc7927, createdName=qiangq, createdTime=Fri May 25 21:37:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096118, encodeId=dc46209611823, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:不清楚<br>经验分享:心内文章,20小时内秒拒,没有原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a138355920, createdName=ms9000000375851820, createdTime=Tue Oct 25 20:39:35 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094795, encodeId=44792094e95c9, content=这杂志怎么突然涨分那么多????, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=528b5683505, createdName=ms5000001621098193, createdTime=Wed Oct 19 19:49:15 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226347, encodeId=2c6c122634eee, content=最近在QJM投稿一篇,第二天就状态就显示ADM:awaiting reviewer selection。到现在第七天,状态依旧没变化。希望好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Tue Jun 14 10:40:16 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2022-06-14 ms4000000138814692

    最近在QJM投稿一篇,第二天就状态就显示ADM:awaiting reviewer selection。到现在第七天,状态依旧没变化。希望好运!

    8

    展开8条回复
共43条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分